Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

ClinicalTrials.gov ID: NCT03954834

Public ClinicalTrials.gov record NCT03954834. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone

Study identification

NCT ID
NCT03954834
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
478 participants

Conditions and interventions

Interventions

  • Tirzepatide Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2, 2019
Primary completion
Oct 4, 2020
Completion
Oct 27, 2020
Last update posted
Oct 19, 2021

2019 – 2020

United States locations

U.S. sites
28
U.S. states
11
U.S. cities
27
Facility City State ZIP Site status
National Research Institute Huntington Park California 90255
National Research Institute Los Angeles California 90057
Catalina Research Institute, LLC Montclair California 91763
Valley Clinical Trials, Inc. Northridge California 91325
National Research Institute Panorama City California 91402
Southern California Dermatology Santa Ana California 92701
Clinical Research of South Florida Coral Gables Florida 33134
Encore Medical Research, LLC Hollywood Florida 33021
Axcess Medical Research Loxahatchee Groves Florida 33470
South Florida Wellness & Clinical Research Institute Margate Florida 33063
Suncoast Research Group, LLC Miami Florida 33135
Agile Clinical Research Trials Atlanta Georgia 30328
Sky Clinical Research Network Atlanta Georgia 30331
Cotton O'Neil Clinic Topeka Kansas 66606
Clinical Research Professionals Chesterfield Missouri 63005
StudyMetrix Research, LLC City of Saint Peters Missouri 63303
Aventiv Research Columbus Ohio 43213
Intend Research Norman Oklahoma 73069
The Corvallis Clinic P.C. Corvallis Oregon 97330
Heritage Valley Medical Group, Inc. Beaver Pennsylvania 15009
Family Medical Associates Levittown Pennsylvania 19056
Preferred Primary Care Physicians Pittsburgh Pennsylvania 15236
Preferred Primary Care Physicians Uniontown Pennsylvania 15401
Dallas Diabetes Endocrine Center Dallas Texas 75230
Clinical Trials of Texas, Inc. San Antonio Texas 78229
Consano Clinical Research Shavano Park Texas 78231
Capital Clinical Research Center Olympia Washington 98502
Rockwood Clinic Research Center Spokane Washington 99220

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03954834, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2021 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03954834 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →